<DOC>
	<DOCNO>NCT00898469</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers relate bone tissue death . PURPOSE : This laboratory study look risk factor bone tissue death young patient acute lymphoblastic leukemia treat clinical trial CCG-1882 .</brief_summary>
	<brief_title>Identifying Risk Factors Bone Tissue Death Young Patients With Acute Lymphoblastic Leukemia Treated Clinical Trial CCG-1882</brief_title>
	<detailed_description>OBJECTIVES : - Identify possible pharmacogenetic risk factor avascular necrosis ( AVN ) pediatric patient receive intensive therapy acute lymphoblastic leukemia clinical trial CCG-1882 . - Compare whether thymidylate synthase 2/2 enhancer repeat genotype vitamin D receptor C/C start site genotype common among patient develop AVN among patient . OUTLINE : This retrospective , cohort , multicenter study . Patients stratify accord gender treatment regimen clinical trial CCG-1882 ( augment vs regular Berlin-Frankfurt-Munster ) . DNA extract slide blast sample previously obtain patient treated clinical trial CCG-1882 . DNA genotyping perform , genotype ( proportion population variant alleles frequency variant allele ) compare patient develop avascular necrosis . PROJECTED ACCRUAL : A total 671 tissue sample patient ( 294 female 377 male ) accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute lymphoblastic leukemia ( ALL ) Has diagnostic ALL blast sample slide available DNA extraction Previously treat clinical trial CCG1882 PATIENT CHARACTERISTICS : Age 10 diagnosis Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>120 Months</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>childhood acute lymphoblastic leukemia</keyword>
</DOC>